A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension

Completed · Phase 3

Conditions studied: Hypertension

In brief

SAFETY EXTENSION STUDY TO THE CORE STUDY CVAH631C2301

Key facts

Study ID

NCT00241007

Run by

Novartis

People needed

836

Starts

2003-12-01

Expected to finish

2005-03-01

Last updated by the study team

2011-11-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• SUCCESSFUL COMPLETION OF STUDY CVAH631C2301

You may not qualify if…

• NONE

Where it is running

• Novartis Pharmaceuticals — East Hanover, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.